Demetrix & Bioengineering Rare Cannabinoids | Jeff Ubersax | #14
Send us a Text Message.
Nick Jikomes talks to Jeff Ubersax, PhD, CEO of the biotechnology company Demetrix (who supported this episode). Jeff discussed the science behind how Demetrix is engineering baker's yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.
Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.
Episode Support: This episode was supported by Demetrix, a biotechnology company using cutting edge fermentation technology to produce rare cannabinoids that are safe, legal, and effective for health and wellness.
Support the Show.
All episodes (audio & video), show notes, transcripts, and more at the M&M Substack
Try Athletic Greens: Comprehensive & convenient daily nutrition. Free 1-year supply of vitamin D with purchase.
Try SiPhox Health—Affordable, at-home bloodwork w/ a comprehensive set of key health marker. Use code TRIKOMES for a 10% discount.
Try the Lumen device to optimize your metabolism for weight loss or athletic performance. Use code MIND for $50 off.
Learn all the ways you can support my efforts
Create your
podcast in
minutes
It is Free